Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation

The development of nonalcoholic fatty liver disease (NAFLD) is associated with increased reactive oxygen species (ROS) production. Previous observations on the contradictory roles of general control nonderepressible 2 (GCN2) in regulating the hepatic redox state under different nutritional condition...

Full description

Bibliographic Details
Main Authors: Juntao Yuan, Zhuoran Yu, Junling Gao, Kai Luo, Xiyue Shen, Bingqing Cui, Zhongbing Lu
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231721003840
_version_ 1818978432745209856
author Juntao Yuan
Zhuoran Yu
Junling Gao
Kai Luo
Xiyue Shen
Bingqing Cui
Zhongbing Lu
author_facet Juntao Yuan
Zhuoran Yu
Junling Gao
Kai Luo
Xiyue Shen
Bingqing Cui
Zhongbing Lu
author_sort Juntao Yuan
collection DOAJ
description The development of nonalcoholic fatty liver disease (NAFLD) is associated with increased reactive oxygen species (ROS) production. Previous observations on the contradictory roles of general control nonderepressible 2 (GCN2) in regulating the hepatic redox state under different nutritional conditions prompted an investigation of the underlying mechanism by which GCN2 regulates ROS homeostasis. In the present study, GCN2 was found to interact with NRF2 and decrease NRF2 expression in a KEAP1-dependent manner. Activation of GCN2 by halofuginone treatment or leucine deprivation decreased NRF2 expression in hepatocytes by increasing GSK-3β activity. In response to oxidative stress, GCN2 repressed NRF2 transcriptional activity. Knockdown of hepatic GCN2 by tail vein injection of an AAV8-shGcn2 vector attenuated hepatic steatosis and oxidative stress in leptin-deficient (ob/ob) mice in an NRF2-dependent manner. Inhibition of GCN2 by GCN2iB also ameliorated hepatic steatosis and oxidative stress in both ob/ob mice and high fat diet-fed mice, which was associated with significant changes in lipid and amino acid metabolic pathways. Untargeted metabolomics analysis revealed that GCN2iB decreased fatty acid and sphingomyelin levels but increased aliphatic amino acid and phosphatidylcholine levels in fatty livers. Collectively, our results provided the first direct evidence that GCN2 is a novel regulator of NRF2 and that specific GCN2 inhibitors might be potential drugs for NAFLD therapy.
first_indexed 2024-12-20T16:43:33Z
format Article
id doaj.art-2df94e71262a4e73b259cbc44b5a34ae
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-12-20T16:43:33Z
publishDate 2022-02-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-2df94e71262a4e73b259cbc44b5a34ae2022-12-21T19:32:58ZengElsevierRedox Biology2213-23172022-02-0149102224Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulationJuntao Yuan0Zhuoran Yu1Junling Gao2Kai Luo3Xiyue Shen4Bingqing Cui5Zhongbing Lu6College of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCollege of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCollege of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCollege of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCollege of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCollege of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaCorresponding author. College of Life Science, University of Chinese Academy of Sciences, 19A Yuquanlu, Beijing, 100049, China.; College of Life Science, University of Chinese Academy of Sciences, Beijing, 100049, ChinaThe development of nonalcoholic fatty liver disease (NAFLD) is associated with increased reactive oxygen species (ROS) production. Previous observations on the contradictory roles of general control nonderepressible 2 (GCN2) in regulating the hepatic redox state under different nutritional conditions prompted an investigation of the underlying mechanism by which GCN2 regulates ROS homeostasis. In the present study, GCN2 was found to interact with NRF2 and decrease NRF2 expression in a KEAP1-dependent manner. Activation of GCN2 by halofuginone treatment or leucine deprivation decreased NRF2 expression in hepatocytes by increasing GSK-3β activity. In response to oxidative stress, GCN2 repressed NRF2 transcriptional activity. Knockdown of hepatic GCN2 by tail vein injection of an AAV8-shGcn2 vector attenuated hepatic steatosis and oxidative stress in leptin-deficient (ob/ob) mice in an NRF2-dependent manner. Inhibition of GCN2 by GCN2iB also ameliorated hepatic steatosis and oxidative stress in both ob/ob mice and high fat diet-fed mice, which was associated with significant changes in lipid and amino acid metabolic pathways. Untargeted metabolomics analysis revealed that GCN2iB decreased fatty acid and sphingomyelin levels but increased aliphatic amino acid and phosphatidylcholine levels in fatty livers. Collectively, our results provided the first direct evidence that GCN2 is a novel regulator of NRF2 and that specific GCN2 inhibitors might be potential drugs for NAFLD therapy.http://www.sciencedirect.com/science/article/pii/S2213231721003840GCN2NRF2KEAP1Hepatic steatosisOxidative stress
spellingShingle Juntao Yuan
Zhuoran Yu
Junling Gao
Kai Luo
Xiyue Shen
Bingqing Cui
Zhongbing Lu
Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
Redox Biology
GCN2
NRF2
KEAP1
Hepatic steatosis
Oxidative stress
title Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
title_full Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
title_fullStr Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
title_full_unstemmed Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
title_short Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
title_sort inhibition of gcn2 alleviates hepatic steatosis and oxidative stress in obese mice involvement of nrf2 regulation
topic GCN2
NRF2
KEAP1
Hepatic steatosis
Oxidative stress
url http://www.sciencedirect.com/science/article/pii/S2213231721003840
work_keys_str_mv AT juntaoyuan inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT zhuoranyu inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT junlinggao inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT kailuo inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT xiyueshen inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT bingqingcui inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation
AT zhongbinglu inhibitionofgcn2alleviateshepaticsteatosisandoxidativestressinobesemiceinvolvementofnrf2regulation